Bina Raghavan
Medical · San Jose, CANPI 1184671901
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by Novo Nordisk at 26.5% of the total. 2025 is the largest year on record at $1,557, 4.5 times the $343 reported in 2021. Among medical clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $32.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Amgen$688
- GSK$439
- CMP Pharma, Inc.$380
- Viiv Healthcare Company$319
- Lilly USA, LLC$312
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,997100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 43 | $1,589 |
| Amgen | 23 | $688 |
| GSK | 12 | $439 |
| CMP Pharma, Inc. | 17 | $380 |
| Viiv Healthcare Company | 7 | $319 |
| Lilly USA, LLC | 9 | $312 |
| Bayer | 7 | $278 |
| Gilead | 8 | $210 |
| Merck | 6 | $209 |
| Pfizer | 8 | $166 |
| Si-bone, Inc. | 1 | $150 |
| Regeneron Healthcare Solutions, Inc. | 3 | $150 |
| Phadia US Inc. | 3 | $145 |
| Astellas Pharma US Inc | 6 | $134 |
| EMD Serono, Inc. | 1 | $112 |
| TELA Bio, Inc. | 1 | $103 |
| AstraZeneca | 5 | $95 |
| Sanofi Pasteur Inc. | 2 | $59 |
| Dynavax Technologies Corporation | 3 | $56 |
| Dexcom, Inc. | 2 | $44 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $42 |
| Sanofi-aventis U.S. LLC | 1 | $37 |
| Mylan Specialty L.p. | 1 | $36 |
| Exact Sciences | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Philips North America LLC | 1 | $23 |
| Bausch Health US, LLC | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $13 |
| Stimwave Technologies Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,997 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 19 | $26,565 |
| JardianceEmpagliflozin | 22 | $17,924 |
| OzempicSemaglutide | 12 | $11,444 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,233 |
| Atorvastatin Calcium | 88 | $688 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $433 |
| Glipizide ErGlipizide | 16 | $279 |
| Levothyroxine Sodium | 24 | $238 |
| Metformin Hcl ErMetformin Hcl | 27 | $220 |
| Metformin Hcl | 45 | $185 |
| Tamsulosin Hcl | 16 | $169 |
| Gabapentin | 11 | $153 |
| Losartan Potassium | 28 | $139 |
| Amlodipine Besylate | 39 | $138 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $1,589 | $38,00931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.
Other medical in San Jose
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.